All News

uniqure NV, the Dutch company which won the first approval for a gene therapy, is taking its technology into the mainstream in a collaboration with Bristol-Myers Squibb to develop treatments for heart diseases

New research suggests that ordinary clay could make a relatively cheap contribution to the decarbonisation struggle. But feasibility remains a long way off

Tibor Navracsics speaks to Science|Business on how he’d spend money from the EU’s €315 billion investment fund

Average success rates have fallen – but applications are being reviewed faster, Commission details at Science|Business conference

A Science|Business Network Brief

A new Science|Businesss Network report looks towards future trends in four key sectors

Speaking at the Science|Business Horizon 2020 conference, Tibor Navracsics defends controversial plans to tap the EU innovation budget, and spoke on the importance of Marie Curie grants for researchers

Limpet teeth have overtaken spider silk as the world’s strongest natural material. As attempts are made to replicate and put this material to use, it is important to look to the IP strategy, say patent attorneys Ben Dempster and Jennifer Unsworth

Carlos Moedas met the great and good of British science this week, delivering a speech at the Royal Society in which he called on researchers to support UK membership of the EU.

Ukrainian researchers and companies to be admitted to Horizon 2020 after deal last week

Wellcome Trust has supported moves promote collaboration and sharing of data by ensuring everyone gets the credit they deserve

Big science is about advancing the frontiers of knowledge. But it is also the source of extraordinary innovation, with huge commercial value and societal impact. So how can Europe become more systematic in extracting this value?

A new online platform ShareIn is connecting biotech companies with investors. This is forcing traditional funders to up their game and cut back on layers of intermediary costs for start-ups, says Jude Cook, co-founder of ShareIn

A £195M fund to address antimicrobial resistance and a $100M VC fund to spur drug discovery in dementia, both announced by the UK government this week, aim to build international coalitions to deal with these threats

Tech giant is to launch five pop-up training sites for small businesses around the country